Academia.eduAcademia.edu

Metallic nanoparticles and in vitro cytotoxicity assessment

2010, Toxicology Letters

AI-generated Abstract

This paper investigates the cytotoxicity of various metallic nanoparticles through in vitro assays, emphasizing the importance of accurate evaluation techniques to prevent misleading results. A comparison of several viability assays, including MTT, WST-1, and LDH, reveals distinct responses of nanoparticles, highlighting the superiority of the WST-1 assay. Furthermore, it presents research findings on poly(anhydride) nanoparticles, demonstrating their safety for oral applications, as indicated by in vitro and in vivo tests that recorded no significant toxic effects under prescribed conditions.

Abstracts / Toxicology Letters 196S (2010) S37–S351 aggregation of NPs at higher concentration) showed no toxicity. doi:10.1016/j.toxlet.2010.03.1148 P303-028 Inhalation toxicity studies with 12 nanomaterials—Comparing effects and distribution in the lung R. Landsiedel, L. Ma-Hock, S. Treumann, V. Strauss, W. Wohlleben, K. Wiench, B.V. Ravenzwaay BASF SE, Germany Several studies demonstrate that identical mass concentrations of nanoparticles are more toxic to the lung than larger particles of similar chemistry. Surface area and particle count concentration have been discussed as critical factor responsible for higher pulmonary toxicity of nanoparticles (Oberdoerster et al., 2000, Res. Rep. Health Eff. Inst. 96, 5–86, Stoeger et al., 2006, EHP 114, 328–333, Wittmaack, 2007, EHP 115, 187–194). We tested the toxicity of 15 substances (12 nanomaterials: SiO2 , surface coated SiO2 , TiO2 P25, coated TiO2 , CeO2 , doted CeO2 , ZrO2 , BaSO4 , carbon black, MWCNT1, MWCNT2 and – for comparison – 3-␮m-scaled materials: quartz, TiO2 , and ZnO) after inhalation exposure. All materials were sufficiently characterized and tested by the well-established short-term inhalation toxicity protocol for nanomaterials (Ma-Hock et al., 2009, Inhal. Toxicol., 21, 102); total protein concentration and polymorphonuclear neutrophils in bronchoalveolar lavage fluide were used as sensitive indicators of effects in the lung. For the tested insoluble nanomaterials we did not see a translocation from the lung to other tissues but the draining lymph nodes, with the exception of coated silica, which was also detected in the spleen. The lung toxicity varied over two orders of magnitude (using mass concentration as dosimetry). And no single material property (chemical identity, size, shape, surface area, surface chemistry) alone could be correlated to the toxic effect. We therefore conclude that nanomaterial’s toxicity is spanning a wide range and is different for different nanomaterials. Hence there is no general nanotoxicity but the toxicity of individual nanomaterials. To determine this toxicity testing is need (until a correlation of material properties with toxic effects has been established). This poster presents a short-term inhalation test for nanomaterials which was developed – and appears to be useful – in efficiently assessing nanomaterials toxicity. doi:10.1016/j.toxlet.2010.03.1149 S281 Our laboratory has used different cell viability assays to evaluate biocompatibility of different metallic nanoparticles. Mitochondrial metabolism (MTT & WST-1 assays) and lysosomal membrane integrity (Neutral red) experiments showed differing results. We found that NPs can react with the components of some of these tests and interfere with the colorimetric assays. According to our data WST-1 was the most efficient assay to assess nanoparticle toxicity. We want to point out that in vitro techniques for toxicity evaluation and their suitability for different NPs must be carefully considered to prevent false-positive or false-negative results. Standardizing nanotoxicological assays in regard to the material used is highly substantial for achieving reproducible results. doi:10.1016/j.toxlet.2010.03.1150 P303-030 Toxicity studies of poly(anhydride) nanoparticles P. Ojer 1 , A. Lopez De Cerain 1 , P. Areses 2 , I. Peñuelas 2 , J.M. Irache 1 1 University of Navarra, Spain, 2 Clínica Universidad de Navarra, Spain In recent years poly(anhydride) nanoparticles have successfully been developed as oral drug delivery systems, immunization or allergy treatment. Given that the obtained results have been rather promising, it is essential to evaluate their toxicity. In this context, conventional (NP), pegylated (PEG-NP) and cyclodextrin (HPCDNP) nanoparticles were prepared by desolvation method, preserved by spray drying and characterized by studying size, zeta potential and morphology. Nanoparticles displayed a size of approximately 170 nm with negative surface charge. Cytotoxicity studies were developed by MTS and LDH assays in HepG2 cells; results showed that after 48 and 72 h incubation, significant cytotoxic effect was observed at the highest concentrations tested (1 and 2 mg/mL). In order to evaluate in vivo toxicity, single oral dose study was performed according to OCDE guideline 425 in female Wistar rats. Taking into account the results obtained, the LD50 for the formulations was found to be higher than 2.000 mg/kg bw. These findings coincide with biodistribution studies with nanoparticles labeled with 99mtechnetium. When nanoparticles were administered orally, they were located in the animals gut, with no evidence of distribution in other organs or nanoparticle translocation. In short, poly(anhydride) nanoparticles (NP, PEG-NP and HPCD-NP) did not show any toxic effects under the experimental conditions used in these studies. doi:10.1016/j.toxlet.2010.03.1151 P303-029 Metallic nanoparticles and in vitro cytotoxicity assessment H. Parkkola, L. Vivero, M. Vega, M. Ramis, J. Querol, J. Sendra Endor Nanotechnologies, Spain Nanotechnology is a rapidly developing field of biomedical research. Among numerous nanomaterials there are wide differences in properties and a growing need for understanding their effects on human health and environment. Biological activity of nanoparticles (NPs) depends on physicochemical characteristics (particle size and distribution, agglomeration state, shape, crystal structure, chemical composition, surface area, surface chemistry and surface charge and porosity) that are not routinely considered in toxicity screening tests. P303-031 Difficulties encountered in the evaluation of the cytotoxicity of bare and coated gold nanoparticles by WST-1 and LDH A. Egizabal 1 , L. Goikoetxea 1 , N. Briz 1 , N. Alvarez 1 , L. Ballester 1 , J. Lorenzo 1 , J. Sendra 2 1 INASMET Tecnalia, France, 2 ENDOR Nanotechnologies, Spain Currently, nanoparticle in vitro cytotoxicity testing is based on methods established for hazard characterization of chemicals, as no nano-specific European standard exists. Many of these tests evaluate the viability of the cells by using different indicator dyes to analyze the absorption/fluorescent emission.